Month: September 2018

S9 Stability Assay – In vitro drug metabolism test for the selection of your lead compounds

MTTlab is pleased to present new “in vitro drug metabolism service” for the selection of your lead compounds. Our collaboration with the University of Padova allows us to offer a S9 Stability Assay for an early knowledge about the metabolism of a new chemical entity. This is valuable in the drug development process by providing…
Read more


September 27, 2018 0

MTTlab at EURO BIO HIGH TECH, Trieste 26/9 – 27/9, 2018

MTTlab Srl will be present at the B2B brokerage @EURO BIO HIGH TECH, in Trieste, Stazione Marittima, on September 26th – 27th, 2018. We look forward to meeting you there!


September 24, 2018 0

MTTlab at 18th Annual Congress of EUSAAT, Linz 23/9 – 26/9, 2018

MTTlab Srl will be present at the 18th Annual Congress of EUSAAT (21st European Congress on Alternatives to Animal Testing), University of Linz, Austria, on September 23rd – 26th, 2018. We look forward to meeting you there!  


September 20, 2018 0

Drug development done better with tissue-specific molecular pharmacology

We are pleased to present our “molecular pharmacology services” to obtain relevant results in a timely and cost-effective manner. In collaboration with Vivomicx, we can enhance the readout of in vivo/ex vivo pharmacology study by evaluating the drug candidate mode of action at a cellular level, by providing molecular pharmacology data in various tissue compartments…
Read more


September 13, 2018 0

In vitro drug metabolism assay for the selection of your lead compounds

MTTlab is pleased to present new “in vitro drug metabolism” service for the selection of your lead compounds. Our collaboration with the University of Padova allows us to offer a Microsomal Stability Assay for early knowledge regarding the metabolism of a new chemical entity. This is valuable in the drug development process as it provides…
Read more


September 6, 2018 0